These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 18322637

  • 1. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity.
    Rosales RL, Chua-Yap AS.
    J Neural Transm (Vienna); 2008; 115(4):617-23. PubMed ID: 18322637
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
    Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M, GSK1358820 Spasticity Study Group.
    J Neurol; 2010 Aug; 257(8):1330-7. PubMed ID: 20358216
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin type A in post-stroke upper limb spasticity.
    Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M, GSK1358820 Spasticity Study Group.
    Curr Med Res Opin; 2010 Aug; 26(8):1983-92. PubMed ID: 20569068
    [Abstract] [Full Text] [Related]

  • 4. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS investigators.
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS, Park YG, Paik NJ, Oh BM, Chun MH, Yang HE, Kim DH, Yi Y, Seo HG, Kim KD, Chang MC, Ryu JH, Lee SU.
    J Neurol Sci; 2015 Oct 15; 357(1-2):192-7. PubMed ID: 26233808
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
    Lee J, Chun MH, Ko YJ, Lee SU, Kim DY, Paik NJ, Kwon BS, Park YG.
    Arch Phys Med Rehabil; 2020 Sep 15; 101(9):1485-1496. PubMed ID: 32497599
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.
    Cardoso E, Rodrigues B, Lucena R, Oliveira IR, Pedreira G, Melo A.
    Arq Neuropsiquiatr; 2005 Mar 15; 63(1):30-3. PubMed ID: 15830061
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L.
    Eur J Neurol; 2001 Nov 15; 8(6):559-65. PubMed ID: 11784339
    [Abstract] [Full Text] [Related]

  • 9. Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.
    Seo HG, Paik NJ, Lee SU, Oh BM, Chun MH, Kwon BS, Bang MS.
    PLoS One; 2015 Nov 15; 10(6):e0128633. PubMed ID: 26030192
    [Abstract] [Full Text] [Related]

  • 10. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
    Yablon SA, Brashear A, Gordon MF, Elovic EP, Turkel CC, Daggett S, Liu J, Brin MF.
    Clin Ther; 2007 Apr 15; 29(4):683-90. PubMed ID: 17617291
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
    Do KH, Chun MH, Paik NJ, Park YG, Lee SU, Kim MW, Kim DK.
    Clin Rehabil; 2017 Sep 15; 31(9):1179-1188. PubMed ID: 28118733
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study.
    Datta Gupta A, Visvanathan R, Cameron I, Koblar SA, Howell S, Wilson D.
    BMC Neurol; 2019 May 11; 19(1):96. PubMed ID: 31078139
    [Abstract] [Full Text] [Related]

  • 13. A systematic review: efficacy of botulinum toxin in walking and quality of life in post-stroke lower limb spasticity.
    Gupta AD, Chu WH, Howell S, Chakraborty S, Koblar S, Visvanathan R, Cameron I, Wilson D.
    Syst Rev; 2018 Jan 05; 7(1):1. PubMed ID: 29304876
    [Abstract] [Full Text] [Related]

  • 14. Combined therapeutic application of botulinum toxin type A, low-frequency rTMS, and intensive occupational therapy for post-stroke spastic upper limb hemiparesis.
    Kakuda W, Abo M, Momosaki R, Yokoi A, Fukuda A, Ito H, Tominaga A, Umemori T, Kameda Y.
    Eur J Phys Rehabil Med; 2012 Mar 05; 48(1):47-55. PubMed ID: 22071503
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, Davies L, Munns M, Hughes A.
    J Rehabil Med; 2009 Jun 05; 41(7):536-44. PubMed ID: 19543664
    [Abstract] [Full Text] [Related]

  • 16. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials.
    Jia S, Liu Y, Shen L, Liang X, Xu X, Wei Y.
    J Stroke Cerebrovasc Dis; 2020 Jun 05; 29(6):104682. PubMed ID: 32305277
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS.
    Neurorehabil Neural Repair; 2012 Sep 05; 26(7):812-21. PubMed ID: 22371239
    [Abstract] [Full Text] [Related]

  • 18. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R, Akturk S, Ersoy Y.
    Eur J Phys Rehabil Med; 2018 Oct 05; 54(5):738-744. PubMed ID: 29422486
    [Abstract] [Full Text] [Related]

  • 19. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Oct 05; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y, Wu T, Hu X, Wang T.
    Eur J Phys Rehabil Med; 2017 Apr 05; 53(2):256-267. PubMed ID: 27834471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.